search

Active clinical trials for "Lipid Metabolism Disorders"

Results 111-120 of 151

Duality of Lipids: the Athlete's Paradox

Insulin ResistanceDiabetes1 more

Accumulation of intramyocellular lipids (IMCLs) due to increased supply of fatty acids can induce defects in the insulin signaling cascade, causing skeletal muscle insulin resistance. However, the causes for muscle insulin resistance are not well understood. The association of elevated IMCLs and insulin resistance has been shown in obese humans and individuals with type 2 diabetes as well as several animal models of insulin resistance. Despite the strong relationship between IMCLs and insulin resistance, this suggested relationship disappears when well-trained endurance athletes are included into this consideration as this group is highly insulin sensitive. This metabolic enigma has been termed the 'athlete's paradox'. The aim of this project is to resolve the mechanisms contributing to the athlete's paradox.

Completed23 enrollment criteria

Dietary Effects on Weight Loss and Lipid Profile in Sedentary Men

MenLife Style3 more

Negative-calorie diet is among the popular dieting guides for weight loss; however, there is still little knowledge about this method. The present study aimed to determine the effects of negative-calorie diet on weight loss and lipid profile, and to compare its efficiency with low-calorie diet in men.

Completed5 enrollment criteria

Almond Consumption and Glycemia

Glucose IntoleranceAppetite Disorders2 more

This study will examine the effects of almonds consumed by adults with different body fat distributions on indices of carbohydrate and lipid metabolism.

Completed5 enrollment criteria

Bilateral; Flank Study With Crown Cooling Insert

Body Fat Disorder

Evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction in the flank using an applicator with and without the Crown Cooling Insert.

Completed22 enrollment criteria

CoolSculpting of the Flank With Alternate Treatment Parameters

Body Fat Disorder

The purpose of this study is to evaluate the safety and efficacy of non-invasive subcutaneous fat layer reduction with an alternative treatment parameter.

Completed22 enrollment criteria

Evaluate the Efficacy and Safety of IBI306 in Subjects With Homozygous Familial Hypercholesterolemia...

Familial Hypercholesterolemia - HomozygousLipid Metabolism Disorders1 more

IBI306 is a bio-innovative drug against proprotein convertase subtilisin 9 (PCSK-9) monoclonal antibody. Currently, cholesterol-lowering drugs with multiple mechanisms of action are on the market or under development. Among them, anti-PCSK-9 monoclonal antibodies have received widespread attention due to their good safety and efficacy. The results of existing preclinical studies show that IBI306 has a clear structure, good stability, and is not inferior to other drugs of its kind in terms of drug activity, animal pharmacokinetics (PK)/pharmacodynamics (PD) and safety. This study is divided into two phases: the dose exploration phase (the first phase) and the confirmatory phase (the second phase). Each stage is divided into screening period, treatment period, and safety follow-up period. The first phase of this research is the randomized design of open labels. The second stage is an open, single-arm design. The main purpose of the first phase of the study: to evaluate the tolerability and safety of multiple-dose repeated administration of IBI306 in the Chinese population with hypercholesterolemia, and to recommend the dose for the second phase. The main purpose of the second phase of the study: to evaluate the effectiveness of IBI306 in the Chinese homozygous familial hypercholesterolemia population. Secondary research purpose: To evaluate the safety and immunogenicity of IBI306 in Chinese homozygous familial hypercholesterolemia population.

Unknown status34 enrollment criteria

A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid...

ArteriosclerosisDiabetes Mellitus1 more

The aim of this study is to assess whether high intensive statin therapy could regress carotid atherosclerotic plaques as determined by High-Resolution Contrast Enhanced Magnetic Resonance imaging (CE-MRI). Enrolled patients have a baseline CE-MRI examination for screening carotid atherosclerotic plaques and are randomized to either low dose of Rosuvastatin (5mg) group or high dose of Rosuvastatin (20mg) group. After 26 weeks, all patients received CE-MRI examination again and each pair of baseline and follow-up CE-MRI assessments was analyzed in a blinded fashion. Moreover, lipid level and major adverse cardiovascular events are also evaluated during follow-up.

Unknown status8 enrollment criteria

Randomized Clinical Trial of HMR(Home Meal Replacement)-Type Omega-3-balanced-diet

Chronic Metabolic DisorderLipid Metabolism Disorders1 more

Investigate whether HMR(Home meal replacement)-type omega-3-balanced-diet can improve clinical laboratory values related to chronic metabolic diseases through reducing lipids and chronic inflammation, and can prevent muscle loss.

Unknown status12 enrollment criteria

Natural History Study of Children With Metachromatic Leukodystrophy

Lipid Metabolism DisordersMetachromatic Leukodystrophy (MLD)14 more

The purpose of this study is evaluate the natural course of disease progression related to gross motor function in children with metachromatic leukodystrophy (MLD).

Terminated12 enrollment criteria

The Effect of a Scratch Off Prompt on Health Engagement

Blood Pressure Check (Hypertension Screening)Cholesterol Test (Lipid Disorder Screening)

The goal of this project is to determine whether prompting the recipient of a health reminder mailing to scratch off targeted area.

Completed3 enrollment criteria
1...111213...16

Need Help? Contact our team!


We'll reach out to this number within 24 hrs